Form 4: Tyra Biosciences Director Buys Shares
Insider Transaction (Form 4)
Rehan Verjee, a Director of Tyra Biosciences, Inc., purchased 972 shares of common stock on September 9, 2026 for $20.58 per share.
Summary
- Open-market purchase: acquired 972 Common Stock at $20.58 ($20,000) on September 9, 2026; holds 972 after (Direct).
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a bullish signal: an insider made an open-market purchase of $20,000, committing personal capital to the stock.
Insider Transactions
Rehan Verjee — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-09 | Open-market purchase | Common Stock | 971.894 | $21 | $20.0K | 971.894 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-09 | Open-market purchase (972 shares) |
Keywords
insider transaction, Form 4, TYRA, Tyra Biosciences, Inc., bullish, Rehan Verjee
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.